Exact claim · Version 1 · Reviewed 2026-07-23
“Compounded semaglutide is the same as an approved product.”
A verdict on this wording and scope, not a universal grade for Semaglutide.
01 · Verdict
Misleading
FDA says compounded drugs are not FDA-approved and are not reviewed for safety, effectiveness, or quality before marketing.
- Evidence basis
- Regulatory or product record
- Scope
- Compounded or otherwise unapproved semaglutide products compared with FDA-approved products.
- Category
- Product equivalence
02 · Primary record
Check the attached evidence
- Editorial review
- Internal editorial review recorded
- Responsible editor
- Anthony Treviso · Founder and responsible editor
- Clinical-review boundary
- Not independently medically reviewed.